Study Looking at Treatment of Advanced Kidney Cancer (Argos)

What we are studying

This study will use an investigational new therapy that involves the use of your own cells to fight your kidney cancer. This is a targeted, personalized therapy that is used in combination with an approved oral chemotherapy drug to fight Clear Cell Carcinoma of the kidney that has spread to other areas in the body.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed advanced kidney cancer also known as Renal Cell Carcinoma.

What is involved

  • Screening visit
  • Treatment period of 8 visits
  • Final study visit
  • And follow-up phone calls every 3 months for up to 3 years

Compensation

To help cover the travel costs of participating in this study, subjects will be given a set amount for travel reimbursement for each treatment visit completed. You will not be paid for visits that you do not complete. You will not be paid for your time or for any wages lost as a result of your being in this study.

Contact Information

Study Coordinator
Joyce Fenstermaker
Email
jfenster@wakehealth.edu
Phone
336-713-3155

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.